Back to Calamos Advisors LLC Calamos Advisors LLC

LLYLLY

Showing 8 of 30 quarters

Position history for Calamos Advisors LLCCalamos Advisors LLC's holdings in Eli Lilly and Company

Yes. Calamos Advisors holds 283,001 shares of LLY (Eli Lilly), worth $339.4M, as of its Q2 2026 13F filing. It reduced the position by 25,496 shares (-8.3%) from Q1 2026. Calamos Advisors has held LLY in every 13F on record since Q1 2019, 30 quarterly filings. LLY is 1.1% of Calamos Advisors' reported 13F portfolio.

Current Value

$339.4M

Current Shares

283,001

Total Value Change

+$83.8M

Total Shares Change

-5,542

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
283,001
-8.3%
$339.4M1.1%$1,197.71
0
2026-Q1
Increased
308,497
+13.2%
$283.7M1.0%$916.88
55
2025-Q4
Decreased
272,554
-0.6%
$292.9M1.1%$1,069.51
0
2025-Q3
Decreased
274,313
-1.5%
$209.3M0.8%$758.22
0
2025-Q2
Increased
278,568
+2.0%
$217.2M0.9%$772.95
44
2025-Q1
Decreased
273,106
-6.5%
$225.6M1.0%$817.26
0
2024-Q4
Increased
291,976
+1.2%
$225.4M0.9%$762.60
44
2024-Q3
Decreased
288,543
-12.9%
$255.6M1.1%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used